|

Tulisokibart Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Also known as: MK-7240, PRA023

Pipeline

Phase 2: 2

Top Sponsors

  • Merck Sharp & Dohme LLC2

Indications

  • Arthritis2
  • Psoriatic Arthritis1
  • Arthritis, Rheumatoid1

Glendale, Arizona1 trial

A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

Arizona Arthritis & Rheumatology Associates, P.C. ( Site 1018)

Phase 2

Sun City, Arizona1 trial

Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

Arizona Arthritis & Rheumatology Associates, P.C. ( Site 5117)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.